Alvotech (ALVO) Current Deferred Revenue (2020 - 2026)
Alvotech's (ALVO) quarterly Current Deferred Revenue came in at $13.1 million in Q1 2026, down 84.91% YoY from $87.0 million in Q1 2025, and down 56.76% on a QoQ basis from $30.4 million in Q4 2025.
Alvotech (ALVO) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Current Deferred Revenue data on file, last reported at $13.1 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 84.91% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (down 84.91% YoY) and the FY2025 annual result came in at $30.4 million, up 90.01% from the prior year.
- Current Deferred Revenue eased to $13.1 million in Q1 2026, from $30.4 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $132.4 million in Q4 2023 to a low of $13.1 million in Q1 2026.
- A 5-year average of $72.3 million and a median of $83.1 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue tumbled 87.93% — and 2025, when it soared 90.01%.
- Tracing ALVO's Current Deferred Revenue over 5 years: stood at $93.9 million in 2022, then surged by 41.0% to $132.4 million in 2023, then plunged by 87.93% to $16.0 million in 2024, then soared by 90.01% to $30.4 million in 2025, then slumped by 56.76% to $13.1 million in 2026.
- The last three Current Deferred Revenue figures came in at $13.1 million (Q1 2026), $30.4 million (Q4 2025), and $80.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 30.36 Mn |
| Sep 30, 2025 | 80.72 Mn |
| Jun 30, 2025 | 60.33 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 15.98 Mn |
| Sep 30, 2024 | 85.50 Mn |
| Jun 30, 2024 | 90.12 Mn |
| Mar 31, 2024 | 88.91 Mn |
| Dec 31, 2023 | 132.44 Mn |
| Jun 30, 2023 | 116.40 Mn |
| Mar 31, 2023 | 54.65 Mn |
| Dec 31, 2022 | 93.93 Mn |
| Jun 30, 2022 | 62.30 Mn |
| Dec 31, 2021 | 74.54 Mn |
| Dec 31, 2020 | 53.07 Mn |